JPWO2021063201A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021063201A5 JPWO2021063201A5 JP2022506438A JP2022506438A JPWO2021063201A5 JP WO2021063201 A5 JPWO2021063201 A5 JP WO2021063201A5 JP 2022506438 A JP2022506438 A JP 2022506438A JP 2022506438 A JP2022506438 A JP 2022506438A JP WO2021063201 A5 JPWO2021063201 A5 JP WO2021063201A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- set forth
- sequence
- antibody
- cdr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910939944 | 2019-09-30 | ||
| CN201910939944.8 | 2019-09-30 | ||
| PCT/CN2020/116417 WO2021063201A1 (zh) | 2019-09-30 | 2020-09-21 | 抗pd-1抗体及其用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022550243A JP2022550243A (ja) | 2022-12-01 |
| JPWO2021063201A5 true JPWO2021063201A5 (https=) | 2023-09-20 |
| JP2022550243A5 JP2022550243A5 (https=) | 2023-09-20 |
Family
ID=75337572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506438A Pending JP2022550243A (ja) | 2019-09-30 | 2020-09-21 | 抗ｐｄ－１抗体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240425593A1 (https=) |
| EP (1) | EP4039704A4 (https=) |
| JP (1) | JP2022550243A (https=) |
| KR (1) | KR20220070201A (https=) |
| CN (1) | CN114206931B (https=) |
| WO (1) | WO2021063201A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3233205A1 (en) * | 2021-09-29 | 2023-04-06 | Yu Xia | Anti-lag3 antibody, pharmaceutical composition and use |
| CN115028726B (zh) * | 2022-03-31 | 2024-01-09 | 浙江特瑞思药业股份有限公司 | 一种抗pd-1纳米抗体及其应用 |
| EP4507725A4 (en) * | 2022-04-14 | 2026-04-22 | Beone Medicines I Gmbh | Stable high-concentration sodium chloride formulations containing a PD-1 antibody and their methods of use |
| CN115785269B (zh) * | 2022-11-01 | 2023-09-22 | 四川大学 | 抗pd-l1的抗体及其应用 |
| CN116854820B (zh) * | 2023-06-26 | 2024-02-06 | 华中科技大学同济医学院附属协和医院 | Pd-1非阻断性清除抗体及其用途 |
| WO2025077741A1 (zh) * | 2023-10-10 | 2025-04-17 | 长春金赛药业有限责任公司 | 抗pd-1单克隆抗体及其应用 |
| CN118388648B (zh) * | 2024-04-16 | 2025-04-01 | 赛业（苏州）生物科技有限公司 | 一种基于全人源抗体鼠的人pd-l1抗体及其制备方法和应用 |
| WO2026041144A1 (zh) * | 2024-08-23 | 2026-02-26 | 百图生科(苏州)智能科技有限公司 | Pd-1激动性抗体及其用途 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| USPP4816P (en) | 1980-09-11 | 1982-01-26 | Mikkelsens Inc. | Kalanchoe plant |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| CN1487996B (zh) | 2000-11-30 | 2010-06-16 | 米德列斯公司 | 用于生产人类抗体的转基因转染色体啮齿动物 |
| CN104250302B (zh) * | 2013-06-26 | 2017-11-14 | 上海君实生物医药科技股份有限公司 | 抗pd‑1抗体及其应用 |
| KR102236367B1 (ko) | 2013-07-26 | 2021-04-05 | 삼성전자주식회사 | DARPin을 포함하는 이중 특이 키메라 단백질 |
| US10323095B2 (en) | 2014-03-17 | 2019-06-18 | Mitsubishi Tanabe Pharma Corporation | Antibody-fynomer conjugates |
| KR102524920B1 (ko) * | 2014-07-22 | 2023-04-25 | 아폴로믹스 인코포레이티드 | 항-pd-1 항체 |
| EP3218409A2 (en) * | 2014-11-11 | 2017-09-20 | Sutro Biopharma, Inc. | Anti-pd-1 antibodies, compositions comprising anti-pd-1 antibodies and methods of using anti-pd-1 antibodies |
| CN105061597B (zh) * | 2015-06-09 | 2016-04-27 | 北京东方百泰生物科技有限公司 | 一种抗pd-1的单克隆抗体及其获得方法 |
| CN114591433A (zh) * | 2015-07-13 | 2022-06-07 | 西托姆克斯治疗公司 | 抗pd-1抗体、可活化抗pd-1抗体及其使用方法 |
| WO2017019846A1 (en) * | 2015-07-30 | 2017-02-02 | Macrogenics, Inc. | Pd-1-binding molecules and methods use thereof |
| US10981991B2 (en) * | 2015-09-29 | 2021-04-20 | Shanghai Zhangjiang Biotechnology Co., Ltd. | PD-1 antibodies and uses thereof |
| CN107286242B (zh) * | 2016-04-01 | 2019-03-22 | 中山康方生物医药有限公司 | 抗pd-1的单克隆抗体 |
| CN106046162B (zh) * | 2016-06-21 | 2019-04-02 | 大庆东竺明生物技术有限公司 | 抗人程序性死亡因子1（pd-1）单克隆抗体的制备及应用 |
| CN107840887B (zh) * | 2016-09-21 | 2022-03-25 | 基石药业（苏州）有限公司 | 一种新的pd-1单克隆抗体 |
| CN106519034B (zh) * | 2016-12-22 | 2020-09-18 | 鲁南制药集团股份有限公司 | 抗pd-1抗体及其用途 |
| RU2768404C2 (ru) * | 2016-12-23 | 2022-03-24 | Ремд Биотерапьютикс, Инк. | Иммунотерапия с применением антител, связывающих белок 1 программируемой смерти клеток (pd-1) |
| KR102678252B1 (ko) * | 2017-09-01 | 2024-06-26 | 쓰촨 케룬-바이오테크 바이오파마수티컬 컴퍼니 리미티드 | 재조합 이중특이적 항체 |
| JP2021502100A (ja) * | 2017-11-08 | 2021-01-28 | ゼンコア インコーポレイテッド | 新規抗ｐｄ−１配列を用いた二重特異性および単一特異性抗体 |
| CN109467603B (zh) * | 2017-11-14 | 2020-02-21 | 拜西欧斯（北京）生物技术有限公司 | 抗pd-1抗体及其制备方法和应用 |
| WO2019141092A1 (zh) | 2018-01-18 | 2019-07-25 | 四川科伦博泰生物医药股份有限公司 | 抗lag-3抗体及其用途 |
| CN116333126A (zh) * | 2018-03-20 | 2023-06-27 | 上海药明生物技术有限公司 | 新型抗pd-1抗体 |
| JP7328324B2 (ja) | 2018-04-24 | 2023-08-16 | アンプソース・バイオファーマ・シャンハイ・インコーポレイテッド | Ｔｉｍ－３に対する抗体およびその使用 |
-
2020
- 2020-09-21 WO PCT/CN2020/116417 patent/WO2021063201A1/zh not_active Ceased
- 2020-09-21 EP EP20870685.3A patent/EP4039704A4/en not_active Withdrawn
- 2020-09-21 KR KR1020227003770A patent/KR20220070201A/ko not_active Ceased
- 2020-09-21 US US17/631,799 patent/US20240425593A1/en not_active Abandoned
- 2020-09-21 CN CN202080055788.XA patent/CN114206931B/zh active Active
- 2020-09-21 JP JP2022506438A patent/JP2022550243A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110799539B (zh) | 抗4-1bb抗体及其制备和使用方法 | |
| KR102340832B1 (ko) | 항 pd-1 항체 및 그의 용도 | |
| CN110050000B (zh) | 含有TGF-β受体的融合蛋白及其医药用途 | |
| TWI771361B (zh) | 人程序性死亡受體pd-1的單株抗體及其片段 | |
| CN107151269B (zh) | 一种pdl-1抗体、其药物组合物及其用途 | |
| KR20240069787A (ko) | 항체 표적화 baff-r 및 이의 사용 | |
| CN114599390A (zh) | 抗体-白介素融合蛋白以及使用方法 | |
| WO2019206095A1 (zh) | 针对tim-3的抗体及其用途 | |
| WO2023143535A1 (zh) | 一种靶向il-18bp的抗体及其应用 | |
| JP7738914B2 (ja) | ＴｒｉＡｘ抗体の組成、その製造方法及び使用方法 | |
| JPWO2021063201A5 (https=) | ||
| WO2023125289A1 (zh) | 抗pd-1抗体及其用途 | |
| KR20240072932A (ko) | B7-h3에 특이적으로 결합하는 항체 | |
| JP2026506070A (ja) | 抗ｃｎｔｎ４抗体及びその使用 | |
| KR20250054821A (ko) | 이중특이적 항체 및 이의 응용 | |
| JPWO2020218951A5 (https=) | ||
| WO2023093744A1 (zh) | 一种双特异性抗原结合蛋白 | |
| CN118076641A (zh) | 抗cd26抗体及其应用 | |
| US20240059771A1 (en) | Anti-cldn-18.2 antibody and use thereof | |
| TW202146446A (zh) | 一種抗pd-l1和egfr的四價雙特異性抗體 | |
| CN106963950B (zh) | 用于治疗肿瘤的联合用药物 | |
| KR20240082201A (ko) | B7-h3 키메라 항원 수용체 및 이의 용도 | |
| WO2024148208A1 (en) | Antibodies specifically recognizing tnfr2 and compositions and uses thereof | |
| JP2026510808A (ja) | ヒト抗体を標的とするメラノーマとその治療方法 | |
| TW202440645A (zh) | 抗muc17*cd3*cd28三特異性抗體 |